Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.

If you are wondering whether Vertex Pharmaceuticals at around US$460 per share still lines up with its fundamentals, you are ...

The Food and Drug Administration approved Vertex Pharmaceuticals' non-opioid painkiller pill, a new alternative for pain relief that comes without the risk of addiction. It's a milestone after a long ...

Vertex Pharmaceuticals reported disappointing Q1 revenue and earnings. The company also revealed it is temporarily pausing part of a phase 1/2 study of experimental cystic fibrosis drug VX-522. Vertex ...